Clinical analysis of the usefulness of letermovir for prevention of cytomegalovirus infection after haploidentical hematopoietic stem cell transplantation

被引：0
|
作者：
马瑞
机构：
[1] Peking Univ Instit Hematol
[2] Peking Univ People’s Hosp
[3] Hematopoietic Stem Cell Transplant
[4] Beijing Key Lab
[5] Natl Clin Hematol Dis Res Center
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2023年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R457.7 [骨髓移植];
学科分类号：
摘要：
Objective To analyze the efficacy and safety of letermovir in primary prophylaxis of cytomegalovirus(CMV) reactivation in patients receiving haploidentical hematopoietic stem cell transplantation.Methods This retrospective,cohort study was conducted using data of patients who underwent haploidentical transplantation at Peking University Institute of Hematology and received letermovir for primary prophylaxis between May 1,
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [41] Clinical Efficacy of Letermovir Prophylaxis for CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience
    Satake, Atsushi
    Ichikawa, Jun
    Saito, Ryo
    Konishi, Akiko
    Hotta, Masaaki
    Nakanishi, Takahisa
    Nakaya, Aya
    Fujita, Shinya
    Ito, Tomoki
    Ishii, Kazuyoshi
    Nomura, Shosaku
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 479 - 480
  • [42] Cytomegalovirus infection following hematopoietic stem cell transplantation
    Einsele, H
    Hebart, H
    Bokemeyer, C
    Kanz, L
    Jahn, G
    Müller, CA
    CMV-RELATED IMMUNOPATHOLOGY, 1998, 21 : 106 - 118
  • [43] Letermovir prophylaxis for cytomegalovirus in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
    Wang, Qingwei
    Liu, Minyuan
    Zhang, Senlin
    Gao, Li
    Chu, Xinran
    Li, Bohan
    Cheng, Shengqin
    Tian, Yuanyuan
    Zhang, Yongping
    Hu, Yixin
    Li, Jie
    Lu, Jun
    Xiao, Peifang
    Liu, Hu
    Hu, Shaoyan
    BONE MARROW TRANSPLANTATION, 2025, : 422 - 424
  • [44] The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation
    Webb, Brandon J.
    Harrington, Rachel
    Schwartz, Jason
    Kammerer, Jennifer
    Spalding, James
    Lee, Edward
    Dodds, Bart
    Kaufusi, Stephanie
    Goodman, Bruce E.
    Firth, Sean D.
    Martin, Greta
    Sorensen, Jeffrey
    Hoda, Daanish
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (05)
  • [45] Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation
    Di Vito, Clara
    Coianiz, Nicolo
    Calvi, Michela
    Terzoli, Sara
    Zaghi, Elisa
    Puccio, Simone
    Frigo, Alessandro
    Mariotti, Jacopo
    De Philippis, Chiara
    Mannina, Daniele
    Sarina, Barbara
    Mineri, Rossana
    Vu, Le-Trilling Thuy Khanh
    Trilling, Mirko
    Castagna, Luca
    Bramanti, Stefania
    Santoro, Armando
    Mavilio, Domenico
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [46] Clinical "Real-World" Experience with Letermovir for Prevention of Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplant Recipients
    Anderson, Anthony D.
    Raja, Mohammed
    Morris, Michele I.
    Komanduri, Krishna V.
    Camargo, Jose F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S317 - S318
  • [47] An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation
    Perez Romero, Pilar
    Blanco, Pilar
    Gimenez, Estela
    Solano, Carlos
    Navarro, David
    FUTURE VIROLOGY, 2015, 10 (02) : 113 - 134
  • [48] An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
    Maffini, Enrico
    Busca, Alessandro
    Costa, Cristina
    Giaccone, Luisa
    Cerrano, Marco
    Curtoni, Antonio
    Cavallo, Rossana
    Bruno, Benedetto
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (11) : 937 - 945
  • [49] Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
    Jinnouchi, Fumiaki
    Mori, Yasuo
    Yoshimoto, Goichi
    Yamauchi, Takuji
    Nunomura, Takuya
    Yurino, Ayano
    Hayashi, Masayasu
    Yuda, Junichiro
    Shima, Takahiro
    Odawara, Jun
    Takashima, Shuichiro
    Kamezaki, Kenjiro
    Kato, Koji
    Miyamoto, Toshihiro
    Akashi, Koichi
    Takenaka, Katsuto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (01) : 96 - 106
  • [50] Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
    Fumiaki Jinnouchi
    Yasuo Mori
    Goichi Yoshimoto
    Takuji Yamauchi
    Takuya Nunomura
    Ayano Yurino
    Masayasu Hayashi
    Junichiro Yuda
    Takahiro Shima
    Jun Odawara
    Shuichiro Takashima
    Kenjiro Kamezaki
    Koji Kato
    Toshihiro Miyamoto
    Koichi Akashi
    Katsuto Takenaka
    International Journal of Hematology, 2022, 115 : 96 - 106
12345